Controversy Surrounds Trump's Executive Order on Glyphosate

President Donald Trump recently signed an executive order aimed at promoting the use of glyphosate, a widely used herbicide, which has drawn significant criticism from health experts and activists. The order emphasizes the importance of glyphosate in agricultural supply chains, arguing that restrictions could negatively impact farmers' ability to meet food demands. The Environmental Protection Agency (EPA) has stated that glyphosate is not likely to be carcinogenic to humans when used as directed.

The Independent

Jillian Michaels, a health and wellness expert and supporter of Robert F. Kennedy Jr.'s Make America Healthy Again movement, has publicly condemned Trump's decision. During an appearance on NewsNation's "The Hill," Michaels described the promotion of glyphosate as "actually devastating," citing numerous studies linking the chemical to an increased risk of non-Hodgkin's lymphoma. She referenced over 170,000 lawsuits against glyphosate's manufacturer, Bayer, which recently agreed to a $7.25 billion settlement related to claims that it failed to adequately warn consumers about the cancer risks associated with its product, Roundup.

The Independent

Michaels expressed skepticism about the economic arguments presented by Trump, stating, "I don’t buy that," and suggested that powerful interests may have influenced the executive order following Bayer's substantial financial settlement.

The Independent

Despite the backlash, Robert F. Kennedy Jr. has supported Trump's executive order, asserting that it would help revitalize U.S. agricultural chemical production and reduce reliance on foreign nations for these essential supplies. Kennedy's endorsement highlights a division among health advocates regarding the use of glyphosate, with some prioritizing agricultural needs over health concerns.

The Independent

Bayer, which acquired Monsanto, the original maker of Roundup, has consistently disputed claims that glyphosate is carcinogenic. The company has indicated that ongoing litigation has posed significant challenges to its operations in the U.S. agricultural market. Bayer CEO Bill Anderson noted that the recent settlement could provide the company with a path to closure regarding its legal troubles, which have persisted for years.

The Independent

While the EPA maintains that glyphosate is safe when used correctly, health advocates like Michaels argue that the evidence suggests otherwise. This discrepancy highlights the ongoing debate over the safety of glyphosate and the influence of corporate interests in agricultural policy.

The Independent

• “It is not a conspiracy theory that glyphosate is linked to cancer,” — Jillian Michaels, Health and Wellness Expert

The Independent

• “I think that somebody powerful called up someone else powerful after paying out $7.25 billion and essentially saying this is an existential threat we need to call in this favor, and they did and it’s exceptionally upsetting,” — Jillian Michaels, Health and Wellness Expert

The Independent

• “Litigation uncertainty has plagued the company for years, and this settlement gives the company a road to closure,” — Bill Anderson, CEO of Bayer

The Independent

This executive order and the surrounding discourse illustrate the complex interplay between agricultural policy, public health, and corporate influence, raising critical questions about the future of pesticide regulation in the United States.

The Independent